Reduction†‡§12 in diabetes-related hospital admissions over 12 months
[187 (13.7%) to 32 (4.7%) at 12 months; P<0.05]
By improving outcomes†‡3-17, the affordable* FreeStyle Libre portfolio creates an opportunity to better manage diabetes and control its high cost2.
Reduction†‡§12 in diabetes-related hospital admissions over 12 months
[187 (13.7%) to 32 (4.7%) at 12 months; P<0.05]
Reduction†‡4 in acute diabetes events.
[6 months post-CGM; P<0.001]
Reduction†‡5 in in-patient hospitalizations in T2D.
[6 months post-CGM; P<0.002]
Connect with an Abbott Account Manager to learn more about how the FreeStyle Libre portfolio can help you and your members.
Product images are for illustrative purposes only.
Medicare coverage is available for the FreeStyle Libre systems if their respective readers are used to review glucose data on some days every month. Medicare and other third party payor criteria apply.
Abbott provides this information as a courtesy; it is subject to change and interpretation. The customer is ultimately responsible for determining the appropriate codes, coverage, and payment policies for individual patients. Abbott does not guarantee third party coverage or payment for our products or reimburse customers for claims that are denied by third party payors.
The FreeStyle Libre 2 system and FreeStyle Libre 3 system are indicated for patients ages 4 and older.
* Based on a comparison of list prices of the FreeStyle Libre personal CGM systems versus competitors’ CGM systems, assuming annual use of one receiver (or equivalent hardware) and quantity of transmitters and/or sensors according to use life. The actual cost to patients may or may not be lower than other CGM systems, depending on the amount covered by insurance, if any.
† Data from this study was collected with the outside US version of the FreeStyle Libre 14 day system. FreeStyle Libre 3 has the same features as FreeStyle Libre 14 day system with real-time glucose alarms. Therefore the study data is applicable to both products.
‡ Data from this study was collected with the outside US version of the FreeStyle Libre 14 day system. FreeStyle Libre 2 has the same features as FreeStyle Libre 14 day system with optional real-time glucose alarms. Therefore the study data is applicable to both products.
§ Represents percentage of people experiencing a diabetes-related hospital admission.
References: 1. Data on file, Abbott Diabetes Care. 2. American Diabetes Association. Diabetes Care (2023). https://doi.org/10.2337/dci23-0085 3. Carlson AL, et al. BMJ Open Diabetes Res Care (2022): https://doi.org/10.1136/bmjdrc-2021-002590 4. Bergenstal, R. J Endocr Soc (2021): https://doi.org/10.1210/jendso/bvab013 5. Miller E, et al. AJMC (2021): https://doi.org/10.37765/ajmc.2021.88780 6. Wright, E. Diabetes Spectr (2021): https://doi.org/10.2337/ds20-0069 7. Charleer S, et al. Diabetes Care (2020): https://doi.org/10.2337/dc19-1610 8. Deshmukh, H. Diabetes Care (2020): https://doi.org/10.2337/dc20-0738 9. Evans M, et al. Diabetes Ther (2022): https://doi.org/10.1007/s13300-022-01253-9 10. Kerr M, et al. Poster presented at the ATTD Conference, Madrid, Spain, February 19-22, 2020. https://doi.org/10.1089/dia.2020.2525.abstracts 11. Kroger, J. Diabetes Ther (2020): https://doi.org/10.1007/s13300-019-00741-9 12. Fokkert, M. BMJ Open Diabetes Res Care (2019): https://doi.org/10.1136/bmjdrc-2019-000809 13. Tyndall, V. Diabetologia (2019): https://doi.org/10.1007/s00125-019-4894-1 14. Yaron, M. Diabetes Care (2019): https://doi.org/10.2337/dc18-0166 15. Campbell, F. Pediatr Diabetes (2018): https://doi.org/10.1111/pedi.12735 16. Haak, T. Diabetes Ther (2017): https://doi.org/10.1007/s13300-016-0223-6 17. Bolinder, J. The Lancet (2016): https://doi.org/10.1016/s0140-6736(16)31535-5
ADC-76902 v1.0
Important Safety Information
FreeStyle Libre 14 day, FreeStyle Libre 2 and FreeStyle Libre 3 systems: Failure to use FreeStyle Libre systems as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose reading and alarms (if enabled) do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855-632-8658 or FreeStyleLibre.us for safety info.
The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. Other trademarks are the property of their respective owners.
No use of any Abbott trademark, trade name, or trade dress in this site may be made without prior written authorization of Abbott Laboratories, except to identify the product or services of the company.
This website and the information contained herein is intended for use by residents of the United States.
ADC-85718 v2.0
Payer.freestylelibre.us/en is a product-specific website intended only for residents of the United States.
If you are a resident of another country, please contact your local Abbott affiliate to obtain the appropriate product information for your country of residence.
ADC-21099 v3.0 07/21
Stay connected